IGC Pharma, Inc. (IGC)

IGC Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 6, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	29	26	18	48	81	19
Market Cap Growth	98.39%	46.64%	-62.80%	-40.34%	321.48%	-76.60%
Enterprise Value	27	25	14	37	79	4
Last Close Price	0.38	0.40	0.34	0.95	1.79	0.49
PE Ratio	-	-1.81	-1.55	-3.16	-8.53	-2.65
PS Ratio	22.75	19.65	19.78	122.03	90.43	4.73
PB Ratio	3.64	3.61	1.21	2.03	2.48	0.73
P/FCF Ratio	-5.82	-4.95	-2.45	-6.29	-6.62	-1.47
P/OCF Ratio	-5.98	-5.08	-2.56	-6.49	-7.52	-2.22
EV/Sales Ratio	25.58	18.90	14.82	93.57	88.34	1.01
EV/EBITDA Ratio	-3.40	-2.78	-1.24	-2.66	-9.62	-0.61
EV/EBIT Ratio	-3.18	-2.60	-1.17	-2.55	-9.09	-0.60
EV/FCF Ratio	-5.67	-4.76	-1.84	-4.83	-6.47	-0.32
Debt / Equity Ratio	0.04	0.05	0.03	0.03	0.03	0.02
Debt / FCF Ratio	-0.06	-0.06	-0.07	-0.08	-0.09	-0.05
Asset Turnover	0.08	0.10	0.04	0.01	0.03	0.13
Inventory Turnover	0.20	0.29	0.15	0.04	0.14	1.76
Quick Ratio	0.76	0.55	1.83	4.53	6.27	6.41
Current Ratio	1.77	1.58	3.41	6.19	9.93	9.12
Return on Equity (ROE)	-126.20%	-116.95%	-59.30%	-52.97%	-29.70%	-24.34%
Return on Assets (ROA)	-47.82%	-45.23%	-32.86%	-29.10%	-16.82%	-13.52%
Return on Capital (ROIC)	-57.43%	-53.12%	-36.25%	-31.25%	-17.87%	-14.12%
Earnings Yield	-46.43%	-49.20%	-63.85%	-31.00%	-10.85%	-37.97%
FCF Yield	-19.68%	-20.20%	-40.83%	-15.89%	-15.11%	-67.82%
Buyback Yield / Dilution	-20.46%	-11.91%	-5.17%	-19.13%	-6.26%	-11.57%
Total Shareholder Return	-20.46%	-11.91%	-5.17%	-19.13%	-6.26%	-11.57%

Source: S&P Capital IQ. Standard template. Financial Sources.